Impact of CYP2C19 point-of-care testing on the clinical outcome in patients receiving personalized clopidogrel therapy: systemic review and meta-analysis.

In our pooled analysis comparing the outcomes of POC genotyping-guided strategies versus standard treatment, we observed a potential reduction in stroke, stent thrombosis, and bleeding rates, although these findings did not reach statistical significance.

also in 111,027 other papers